Research Article
Insulin Resistance and Cardiovascular Risks in Different Groups of Hemodialysis Patients: A Multicenter Study
Table 1
Characteristics of hemodialysis patients.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Categorical data is shown as n (%). Continuous data is presented as mean ± SD or median (interquartile range). P values calculated using Chi-square test, independent-samples T test, or Mann-Whitney U test. The diagnosed values were defined by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative Work Group. BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; CVD, cardiovascular diseases; CCI, Charlson comorbidity index; PA, physical activity; MET, metabolic equivalent minute/ week; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; IFG, impaired fasting glucose; CaxPO4, calcium phosphate product; iPTH, intact parathyroid hormone; Hcy, homocysteine; hs-CRP, high sensitive C-reactive protein; K, serum potassium; HOMA-IR, homeostatic model assessment of insulin resistance; BUN, blood urea nitrogen; FPG, fasting plasma glucose; FPI: fasting plasma insulin. |